212 related articles for article (PubMed ID: 33200254)
21. Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice.
Akita Y; Kuroshima S; Nakajima K; Hayano H; Kanai R; Sasaki M; Sawase T
J Bone Miner Metab; 2018 Sep; 36(5):547-559. PubMed ID: 29043461
[TBL] [Abstract][Full Text] [Related]
22. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
23. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.
Aguirre JI; Akhter MP; Kimmel DB; Pingel JE; Williams A; Jorgensen M; Kesavalu L; Wronski TJ
J Bone Miner Res; 2012 Oct; 27(10):2130-43. PubMed ID: 22623376
[TBL] [Abstract][Full Text] [Related]
24. Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Tanaka Y; Aung KT; Ono M; Mikai A; Dang AT; Hara ES; Tosa I; Ishibashi K; Ono-Kimura A; Nawachi K; Kuboki T; Oohashi T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884630
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.
Kuroshima S; Yamashita J
Bone; 2013 Sep; 56(1):101-9. PubMed ID: 23727433
[TBL] [Abstract][Full Text] [Related]
26. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.
Soundia A; Hadaya D; Esfandi N; de Molon RS; Bezouglaia O; Dry SM; Pirih FQ; Aghaloo T; Tetradis S
Bone; 2016 Sep; 90():133-41. PubMed ID: 27327410
[TBL] [Abstract][Full Text] [Related]
27.
Wu S; Li F; Tan J; Ye X; Le Y; Liu N; Everts V; Wan Q
Front Cell Infect Microbiol; 2022; 12():886411. PubMed ID: 35811676
[TBL] [Abstract][Full Text] [Related]
28. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
[TBL] [Abstract][Full Text] [Related]
29. Zoledronate Impairs Socket Healing after Extraction of Teeth with Experimental Periodontitis.
Soundia A; Hadaya D; Esfandi N; Gkouveris I; Christensen R; Dry SM; Bezouglaia O; Pirih F; Nikitakis N; Aghaloo T; Tetradis S
J Dent Res; 2018 Mar; 97(3):312-320. PubMed ID: 28954199
[TBL] [Abstract][Full Text] [Related]
30. Zoledronate Inhibits Osteoclast Differentiation via Suppressing Vascular Endothelial Growth Factor Receptor 2 Expression.
Nakagawa T; Ohta K; Uetsuki R; Kato H; Naruse T; Murodumi H; Yokoyama S; Sakuma M; Ono S; Takechi M
Biochem Genet; 2020 Jun; 58(3):473-489. PubMed ID: 32274606
[TBL] [Abstract][Full Text] [Related]
31. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis.
Kim HJ; Kim HJ; Choi Y; Bae MK; Hwang DS; Shin SH; Lee JY
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909508
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate.
Ervolino E; Statkievicz C; Toro LF; de Mello-Neto JM; Cavazana TP; Issa JPM; Dornelles RCM; de Almeida JM; Nagata MJH; Okamoto R; Casatti CA; Garcia VG; Theodoro LH
Bone; 2019 Mar; 120():101-113. PubMed ID: 30339908
[TBL] [Abstract][Full Text] [Related]
33. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
Shibahara T
Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
[TBL] [Abstract][Full Text] [Related]
34. Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw.
Sun Y; Kaur K; Kanayama K; Morinaga K; Park S; Hokugo A; Kozlowska A; McBride WH; Li J; Jewett A; Nishimura I
J Biol Chem; 2016 Sep; 291(39):20602-16. PubMed ID: 27514746
[TBL] [Abstract][Full Text] [Related]
35. A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma.
Howie RN; Borke JL; Kurago Z; Daoudi A; Cray J; Zakhary IE; Brown TL; Raley JN; Tran LT; Messer R; Medani F; Elsalanty ME
PLoS One; 2015; 10(7):e0132520. PubMed ID: 26186665
[TBL] [Abstract][Full Text] [Related]
36. Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.
Hadad H; Matheus HR; Pai SI; Souza FA; Guastaldi FPS
Arch Oral Biol; 2024 Mar; 159():105875. PubMed ID: 38160519
[TBL] [Abstract][Full Text] [Related]
37. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid.
Mozzati M; Martinasso G; Maggiora M; Scoletta M; Zambelli M; Carossa S; Oraldi M; Muzio G; Canuto RA
Clin Oral Investig; 2013 May; 17(4):1259-66. PubMed ID: 22864527
[TBL] [Abstract][Full Text] [Related]
38. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
39. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
Mavrokokki T; Cheng A; Stein B; Goss A
J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
[TBL] [Abstract][Full Text] [Related]
40. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
Shudo A; Kishimoto H; Takaoka K; Noguchi K
Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
